Storek, Jan |
NCT03456817: HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD Prophylaxis |
|
|
| Recruiting | 2 | 200 | Canada | Treatment Arm - high dose ATG, Control Arm - standard of care | AHS Cancer Control Alberta | Graft-versus-host-disease, Relapse | 09/26 | 09/26 | | |
Faruqi, Muhammad |
NCT03550391: Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases |
|
|
| Recruiting | 3 | 206 | Canada, US | Memantine, Hippocampal-avoidant (HA-WBRT) Radiotherapy, Stereotactic Radiosurgery (SRS) | Canadian Cancer Trials Group, Alliance for Clinical Trials in Oncology, NRG Oncology | Brain Metastases | 06/27 | 12/27 | | |
NCT04474925: Pre- Versus Post-operative SRS for Resectable Brain Metastases |
|
|
| Recruiting | 3 | 88 | Canada | Brain Surgery, Stereotactic Radiosurgery, SRS | AHS Cancer Control Alberta | Brain Metastases | 09/25 | 08/26 | | |
UNSCARRed, NCT03737721: The Study: UNresctable Squamous Cell Carcinoma Treated With Avelumab and Radical Radiotherapy |
|
|
| Active, not recruiting | 2 | 20 | Canada | Avelumab and Radical radiotherapy | AHS Cancer Control Alberta, EMD Serono, Alberta Cancer Foundation | Squamous Cell Carcinoma of the Skin | 11/22 | 12/24 | | |
Yip, Steven |
CCTG PR21, NCT04663997: 177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer |
|
|
| Active, not recruiting | 2 | 200 | Canada | 177Lu-PSMA-617, Docetaxel | Canadian Cancer Trials Group, Prostate Cancer Canada, Novartis Pharmaceuticals | Prostate Cancer | 06/25 | 12/25 | | |
| Recruiting | N/A | 10000 | Canada | | Exactis Innovation | Cancer | 07/25 | 07/25 | | |
| Terminated | N/A | 128 | Canada | [18F]-PSMA-1007 | AHS Cancer Control Alberta | Prostate Cancer | 11/24 | 11/24 | | |
Lee, Sangjune |
NCT05370144: A Study Involving Neoadjuvant Chemoradiotherapy with Hypofractionated Radiotherapy in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma |
|
|
| Recruiting | N/A | 42 | Canada | Hypofractionated radiotherapy | AHS Cancer Control Alberta | Esophageal Cancer | 02/27 | 02/28 | | |